In 2022 this medication was approved as a first-line treatment for diabetes
For most people, daily doses of 2,000 mg or less are safe
However, in contrast to glutamine uptake, cell membrane glutamate transport (GLAST1) is shifted from the cell membrane to an intracellular location in breast cancer cells as shown in Figure 3, effectively uncoupling extracellular glutamate from inhibiting the intracellular glutaminases
Only 15% of patients prescribed GLP-1s for weight loss were still taking the medications two years later, according to an analysis of pharmacy claims posted on July 10th by the pharmacy benefit manager, Prime Therapeutics
I., Hadjadj, S., Lawson, J., Mosenzon, O., Tuttle, K., Vrhnjak, B., Rasmussen, S., & Bain, S
Accessed 21Oct21